Fact EV/EBIT
Was ist das EV/EBIT von Fact?
EV/EBIT von Fact, Inc. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Industrials Sektor auf OTC im Vergleich zu Fact
Was macht Fact?
Fact, Inc. engages in the art verification and authentication, sports memorabilia, and fine art businesses. It is developing a front-end user interface, as well as modifying existing ballistics firmware for a comprehensive verification, tracking, and reporting system using white light interferometry to take a non-destructive 3D digital fingerprint of the art using approximately 100,000 unique images. The company was formerly known as Tiburon International Trading Corp. and changed its name to Fact, Inc. in November 2020. FACT, Inc. is headquartered in Toronto, Canada. As of October 5, 2020, Fact, Inc. operates as a subsidiary of Kryptos Art Technologies, Inc.
Unternehmen mit ev/ebit ähnlich Fact
- Frequency Exchange hat EV/EBIT von N/A
- Torstar hat EV/EBIT von N/A
- Miragen Therapeutics Inc hat EV/EBIT von N/A
- Mitesco hat EV/EBIT von N/A
- Monumental Minerals Corp hat EV/EBIT von N/A
- C4 Therapeutics hat EV/EBIT von N/A
- Fact hat EV/EBIT von N/A
- BioCardia hat EV/EBIT von N/A
- Comprehensive Healthcare Systems hat EV/EBIT von N/A
- Progenity hat EV/EBIT von N/A
- THC Therapeutics hat EV/EBIT von N/A
- RiceBran Technologies hat EV/EBIT von N/A
- BioAtla hat EV/EBIT von N/A